1
Grosenbaugh DA, De Luca K, Durand P-Y et al. Characterization of recombinant OspA in
two different Borrelia vaccines with respect to immunological response and its relationship
to functional parameters. BMC Veterinary Research. 2018;14:312. https://doi.org/10.1186/
s12917-018-1625-7. Accessed November 7, 2018.
2
Rice Conlon JA, Mather TN, Tanner P. Effi cacy of a nonadjuvanted outer surface protein
A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia
burgdorferi.* Vet Ther. 2000;1(2):98-107.
Grosenbaugh DA, De Luca K, Durand P-Y et al. Characterization of recombinant OspA in
vaccines with respect to immunological response and its relationship
2018;14:312. https://doi.org/10.1186/
Rice Conlon JA, Mather TN, Tanner P. Effi cacy of a nonadjuvanted outer surface protein
A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia
TARGETED TARGETED
LYME LYME
PROTECTION PROTECTION
THE ONLY canine Lyme vaccine that
is nonadjuvanted and contains a single
protein, lipidated OspA
A lipidated form of OspA has been
shown to be more immunogenic than
a nonlipidated form of OspA
1
Effective protection that blocks
Borrelia burgdorferi while it's still in
the tick
2
RECOMBITEK
®
RECOMBITEK Lyme has all the
protection dogs need, and none
of the antigens they don't.
TARGETED
LYME
PROTECTION
MEANS MEANS MEANS
PURE. PURE. PURE. PURE. PURE.
RECOMBITEK
®
is a registered trademark of
Boehringer Ingelheim Animal Health USA Inc.
©2019 Boehringer Ingelheim Animal Health
USA Inc. All rights reserved. PET-0911-REC0119.
A Boehringer Ingelheim Vaccine
PetVaccinesClinic.com